| none |
WILSON BANK HOLDING CO |
MCDEARMAN JOHN |
Director
Officer
|
2026-01-23 |
M - D |
1,500 |
0.00 |
0.00 |
2,000 |
| WRB |
BERKLEY W R CORP |
MS&AD Insurance Group Holdings, Inc. |
|
2026-01-23 |
P - A |
201,081 |
66.77 |
13,426,158.26 |
54,422,585 |
| WRB |
BERKLEY W R CORP |
MS&AD Insurance Group Holdings, Inc. |
|
2026-01-23 |
P - A |
166,919 |
67.18 |
11,213,668.50 |
54,589,504 |
| WRB |
BERKLEY W R CORP |
MS&AD Insurance Group Holdings, Inc. |
|
2026-01-23 |
P - A |
201,081 |
66.77 |
13,426,158.26 |
54,422,585 |
| WRB |
BERKLEY W R CORP |
MS&AD Insurance Group Holdings, Inc. |
|
2026-01-23 |
P - A |
166,919 |
67.18 |
11,213,668.50 |
54,589,504 |
| ATXS |
Astria Therapeutics, Inc. |
Matthews Andrea |
|
2026-01-23 |
D - D |
32,812 |
0.00 |
0.00 |
0 |
| ATXS |
Astria Therapeutics, Inc. |
Matthews Andrea |
|
2026-01-23 |
D - D |
20,000 |
0.00 |
0.00 |
0 |
| ATXS |
Astria Therapeutics, Inc. |
Matthews Andrea |
|
2026-01-23 |
D - D |
262,500 |
0.00 |
0.00 |
0 |
| ABOS |
Acumen Pharmaceuticals, Inc. |
Meisner Derek M |
Officer
|
2026-01-23 |
S - D |
5,633 |
1.90 |
10,717.91 |
173,999 |
| ATXS |
Astria Therapeutics, Inc. |
Milne Jill C. |
|
2026-01-23 |
D - D |
4,377 |
0.00 |
0.00 |
0 |
| ATXS |
Astria Therapeutics, Inc. |
Milne Jill C. |
|
2026-01-23 |
D - D |
195,000 |
0.00 |
0.00 |
0 |
| ATXS |
Astria Therapeutics, Inc. |
Milne Jill C. |
|
2026-01-23 |
D - D |
761,000 |
0.00 |
0.00 |
0 |
| ATXS |
Astria Therapeutics, Inc. |
Morabito Christopher |
|
2026-01-23 |
D - D |
80,000 |
0.00 |
0.00 |
0 |
| ATXS |
Astria Therapeutics, Inc. |
Morabito Christopher |
|
2026-01-23 |
D - D |
262,500 |
0.00 |
0.00 |
0 |
| NYC |
American Strategic Investment Co. |
New York City Advisors, LLC |
10% Owner
|
2026-01-23 |
P - A |
1,365 |
10.38 |
14,168.70 |
1,067,292 |
| NYC |
American Strategic Investment Co. |
New York City Advisors, LLC |
10% Owner
|
2026-01-23 |
P - A |
1,365 |
10.38 |
14,168.70 |
1,067,292 |
| NLCP |
NewLake Capital Partners, Inc. |
Coniglio Anthony |
Director
Officer
|
2026-01-23 |
F - D |
10,771 |
15.00 |
161,565.00 |
606,439 |
| SLGL |
Sol-Gel Technologies Ltd. |
Opaleye Management Inc. |
10% Owner
|
2026-01-23 |
P - A |
1,151 |
55.98 |
64,434.02 |
449,844 |
| ORKA |
Oruka Therapeutics, Inc. |
Dambkowski Carl |
Director
|
2026-01-23 |
J - A |
116,483 |
0.00 |
0.00 |
116,483 |
| ORKA |
Oruka Therapeutics, Inc. |
Quinlan Paul T |
Officer
|
2026-01-23 |
A - A |
32,500 |
0.00 |
0.00 |
32,500 |
| ORKA |
Oruka Therapeutics, Inc. |
Quinlan Paul T |
Officer
|
2026-01-23 |
A - A |
130,000 |
0.00 |
0.00 |
130,000 |
| ORKA |
Oruka Therapeutics, Inc. |
Klein Lawrence Otto |
Director
Officer
|
2026-01-23 |
A - A |
76,700 |
0.00 |
0.00 |
929,038 |
| ORKA |
Oruka Therapeutics, Inc. |
Klein Lawrence Otto |
Director
Officer
|
2026-01-23 |
A - A |
306,700 |
0.00 |
0.00 |
306,700 |
| ORKA |
Oruka Therapeutics, Inc. |
Agarwal Arjun |
Officer
|
2026-01-23 |
A - A |
17,500 |
0.00 |
0.00 |
19,258 |
| ORKA |
Oruka Therapeutics, Inc. |
Agarwal Arjun |
Officer
|
2026-01-23 |
A - A |
70,000 |
0.00 |
0.00 |
70,000 |